Atlas Trials

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

Clinical trial NCT05786937 · UNKNOWN

Trial details

NCT number
NCT05786937
Sponsor
University of Sao Paulo General Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Vaccine
Start date
2023-06-01
Primary completion
2023-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.